Clinical Trial Detail

NCT ID NCT01786265
Title Finite Androgen Ablation vs. Finite Androgen Ablation in Combination With Abiraterone Acetate and Prednisone
Recruitment Active, not recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors M.D. Anderson Cancer Center
Indications

prostate adenocarcinoma

Therapies

Goserelin

Degarelix

Abiraterone

Prednisone

Leuprolide

Age Groups: adult

No variant requirements are available.